Biotech Values

[dewophile]

The stock is currently trading above the buyout price, implying that investors expect a sweetened offer

The stock is still cheap by historical standards, but bio valuations are what they are these days
I personally still like the vaccine business - you don't have to deal with patent cliffs so I think companies should command higher multiples on earnings than traditional drug cos all things being equal